Wu-Wong J R, Budzik G P, Devine E M, Opgenorth T J
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064.
Biochem Biophys Res Commun. 1990 Sep 28;171(3):1291-6. doi: 10.1016/0006-291x(90)90826-9.
An enzyme activity which converts human big endothelin (1-38) to endothelin (1-21) and a C-terminal fragment (CTF, 22-38) was identified in a plasma membrane fraction prepared from rat lung. The conversion activity was optimal at pH 4.0, was inhibited by Pepstatin-A (IC50 = 20 nM), but was not affected by TLCK, Aprotinin, PMSF, E-64, Bestatin, Phosphoramidon or Thiorphan at 40 microM. Metal ions activated the activity by 1.5 - 2.5 fold in the order of Mn+2 greater than Zn+2 = Ca+2 greater than Ba+2. These data suggest that a Pepstatin-A inhibitable, metal ion related aspartic protease may be involved in the conversion of big endothelin to endothelin in rat lung.